International

On the back of many years dedicated to the refinement and perfection of company standards and operational practices in the United States, Amneal continues to expand its business around the world and is now a global resource for quality generic products.

From the company’s international headquarters in Zug, Switzerland, Amneal is comfortably situated to leverage its scientific expertise and formidable assets in the service of key global markets.

Pursuing a global strategy designed around leveraging its internal pipeline across global markets, Amneal is expanding responsibly, primarily through front-end acquisitions and partnerships with established local companies. This facilitates the replication of the company’s well-earned domestic success and uniquely positions Amneal to satisfy growing customer demand today, and tomorrow.

We invite you to learn more about Amneal’s international operations below.

United Kingdon

United Kingdon

Amneal operates as Creo Pharma in the United Kingdom. Click below to learn more about the company’s UK business.

Creo Pharma >>

Scandinavia

Scandinavia

Amneal Nordic ApS services Denmark, Norway, Sweden and Finland.

Amneal Nordic ApS >>

Spain

Spain

Pharmagenus joined the Amneal family in 2014. Learn more about our operations in Spain under the Pharmagenus brand.

Pharmagenus >>

Australia

Australia

Formerly Scentia Pharmaceuticals, Amneal Pharma Australia offers more than 90 molecules to the Australian and New Zealand markets.

Amneal Australia Pty Ltd >>